The Take-Two Interactive CEO discussed the expected retail price for the game, and it's polarized fans on what constitutes good value.
Achieved YUTREPIA® net product sales of $148.3 million for the full year 2025 with $90.1 million in the fourth quarterMore than 3,600 unique ...
Management prioritizes 5%–10% weight loss and acetazolamide titration guided by Frisén grading, OCT, and visual fields; refractory or vision-threatening disease may need ONSF or CSF shunting.
The 2026 European Association of Urology (EAU) annual meeting featured a managing advanced disease in renal and rare cancer ...
Taletrectinib is already approved in the U.S., China and Japan for advanced ROS1-positive non-small cell lung cancer TOKYO and NEW YORK, NY., Mar 27, 2026 - (JCN Newswire) - Eisai Co., Ltd.
Louder on MSN
Audio-Technica AT-LP70XBT review: an automatic turntable all-but guaranteed to go the distance
This automatic record player is the gold-standard for entry level turntables, with beginner-friendly operation and hi-fi ...
PREVAiLS is a pivotal, global, 500-participant Phase 3 study to evaluate efficacy and safety of pridopidine, an investigational drug, in slowing ALS progression (ALSFRS-R) in early, rapidly progressiv ...
IV therapy — on-demand infusions of customer-chosen vitamins and nutrients — which previously had a reputation for being a superficial hangover cure, primarily among celebrities like Kendall Jenner ...
Over a year of discomfort, antibiotics, and dismissive doctors, a surgery finally revealed what was happening to her body.
Long-term lithium therapy remains the most effective maintenance treatment for bipolar disorder, yet it poses a significant ...
Nuvation Bio Inc. (NYSE: NUVB), a global oncology company focused on tackling some of the toughest challenges in cancer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results